Baidu
map

2021 年 PACES 儿科患者心血管植入式电子设备的适应症和管理专家共识声明

2021-08-01 美国儿科和先天性电生理协会 Heart Rhythm . 2021 Jul 29;S1547-5271(21)01916-0

鉴于当前时代心血管植入式电子设备 (CIED) 和患者日益复杂,实践指南必然变得越来越具体。本文件是一份专家共识声明,旨在更新和进一步描述定义为 21 岁以下的儿科患者 CIED 的适应症和管理,主要

中文标题:

2021 年 PACES 儿科患者心血管植入式电子设备的适应症和管理专家共识声明

发布日期:

2021-08-01

简要介绍:

鉴于当前时代心血管植入式电子设备 (CIED) 和患者日益复杂,实践指南必然变得越来越具体。本文件是一份专家共识声明,旨在更新和进一步描述定义为 21 岁以下的儿科患者 CIED 的适应症和管理,主要关注特定疾病环境中 CIED 的适应症类别。该文件还强调了先前发布的成人和儿科 CIED 建议之间的差异,并为潜在的重要差异提供了基本原理。该文件解决了中低收入国家对 CIED 访问的一些威慑以及规避这些威慑的策略。文件部分由编写委员会成员根据他们的专业知识进行划分和起草。推荐意见代表了整个编写委员会的共识意见,按推荐级别和证据水平分级。本文件中提到的几个问题要么不适合临床试验,要么属于罕见疾病,在这些情况下,建议是基于共识专家意见。此外,即使有大量数据支持,具体建议也不能取代临床判断和患者特定决策的需要。这些建议已向儿科和先天性电生理学会 (PACES) 成员开放征求公众意见,并由心律学会 (HRS) 的科学和临床文件委员会、美国心脏协会 (AHA) 的科学咨询和协调委员会进行外部审查。 )、美国心脏病学会 (ACC) 和欧洲儿科和先天性心脏病学会 (AEPC)。该文件得到了所有合作者和亚太心律协会 (APHRS)、印度心律协会 (IHRS) 和拉丁美洲心律协会 (LAHRS) 的认可。本文件有望为临床医生和患者提供支持,以允许在儿科患者中适当使用 CIED、适当的 CIED 管理和适当的随访。

相关资料下载:
[AttachmentFileName(sort=1, fileName=66.pdf)] GetToolGuiderByIdResponse(projectId=1, id=c4fd61c002152e4b, title=2021 年 PACES 儿科患者心血管植入式电子设备的适应症和管理专家共识声明 , enTitle=, guiderFrom=Heart Rhythm . 2021 Jul 29;S1547-5271(21)01916-0, authorId=0, author=, summary=鉴于当前时代心血管植入式电子设备 (CIED) 和患者日益复杂,实践指南必然变得越来越具体。本文件是一份专家共识声明,旨在更新和进一步描述定义为 21 岁以下的儿科患者 CIED 的适应症和管理,主要, cover=, journalId=0, articlesId=null, associationId=680, associationName=美国儿科和先天性电生理协会, associationIntro=null, copyright=0, guiderPublishedTime=Sun Aug 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span class="VIiyi" lang="zh-CN"><span class="JLqJ4b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="0">鉴于当前时代心血管植入式电子设备 (CIED) 和患者日益复杂,实践指南必然变得越来越具体。本文件是一份专家共识声明,旨在更新和进一步描述定义为 21 岁以下的儿科患者 CIED 的适应症和管理,主要关注特定疾病环境中 CIED 的适应症类别。该文件还强调了先前发布的成人和儿科 CIED 建议之间的差异,并为潜在的重要差异提供了基本原理。该文件解决了中低收入国家对 CIED 访问的一些威慑以及规避这些威慑的策略。文件部分由编写委员会成员根据他们的专业知识进行划分和起草。推荐意见代表了整个编写委员会的共识意见,按推荐级别和证据水平分级。本文件中提到的几个问题要么不适合临床试验,要么属于罕见疾病,在这些情况下,建议是基于共识专家意见。此外,即使有大量数据支持,具体建议也不能取代临床判断和患者特定决策的需要。这些建议已向儿科和先天性电生理学会 (PACES) 成员开放征求公众意见,并由心律学会 (HRS) 的科学和临床文件委员会、美国心脏协会 (AHA) 的科学咨询和协调委员会进行外部审查。 )、美国心脏病学会 (ACC) 和欧洲儿科和先天性心脏病学会 (AEPC)。该文件得到了所有合作者和亚太心律协会 (APHRS)、印度心律协会 (IHRS) 和拉丁美洲心律协会 (LAHRS) 的认可。本文件有望为临床医生和患者提供支持,以允许在儿科患者中适当使用 CIED、适当的 CIED 管理和适当的随访。</span></span></p>, tagList=[TagDto(tagId=266, tagName=心血管)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12612, appHits=64, showAppHits=0, pcHits=1312, showPcHits=12547, likes=0, shares=7, comments=5, approvalStatus=1, publishedTime=Thu Aug 12 21:23:30 CST 2021, publishedTimeString=2021-08-01, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Thu Aug 12 21:23:07 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Mon Jan 01 20:54:30 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])
66.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1008046, encodeId=21ac100804626, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48695395402, createdName=ms2000000778072906, createdTime=Sun Aug 15 12:17:16 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007915, encodeId=7d01100e915b1, content=需要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/4f10b5177a794339bc579b57c6b95f39/a2c85165c1bc454aa3e382cae54ca6ee.jpg, createdBy=9b2d5573294, createdName=恣意妄为, createdTime=Sat Aug 14 21:27:55 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007735, encodeId=5a75100e735f7, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5185543565, createdName=ms4000000408264698, createdTime=Fri Aug 13 22:35:20 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007527, encodeId=d5e5100e52763, content=作息, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=258a2211002, createdName=120d5e71m96(暂无昵称), createdTime=Fri Aug 13 09:48:42 CST 2021, time=2021-08-13, status=1, ipAttribution=)]
    2021-08-15 ms2000000778072906

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1008046, encodeId=21ac100804626, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48695395402, createdName=ms2000000778072906, createdTime=Sun Aug 15 12:17:16 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007915, encodeId=7d01100e915b1, content=需要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/4f10b5177a794339bc579b57c6b95f39/a2c85165c1bc454aa3e382cae54ca6ee.jpg, createdBy=9b2d5573294, createdName=恣意妄为, createdTime=Sat Aug 14 21:27:55 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007735, encodeId=5a75100e735f7, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5185543565, createdName=ms4000000408264698, createdTime=Fri Aug 13 22:35:20 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007527, encodeId=d5e5100e52763, content=作息, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=258a2211002, createdName=120d5e71m96(暂无昵称), createdTime=Fri Aug 13 09:48:42 CST 2021, time=2021-08-13, status=1, ipAttribution=)]
    2021-08-14 恣意妄为

    需要积分

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1008046, encodeId=21ac100804626, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48695395402, createdName=ms2000000778072906, createdTime=Sun Aug 15 12:17:16 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007915, encodeId=7d01100e915b1, content=需要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/4f10b5177a794339bc579b57c6b95f39/a2c85165c1bc454aa3e382cae54ca6ee.jpg, createdBy=9b2d5573294, createdName=恣意妄为, createdTime=Sat Aug 14 21:27:55 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007735, encodeId=5a75100e735f7, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5185543565, createdName=ms4000000408264698, createdTime=Fri Aug 13 22:35:20 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007527, encodeId=d5e5100e52763, content=作息, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=258a2211002, createdName=120d5e71m96(暂无昵称), createdTime=Fri Aug 13 09:48:42 CST 2021, time=2021-08-13, status=1, ipAttribution=)]
    2021-08-13 ms4000000408264698

    good

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1008046, encodeId=21ac100804626, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48695395402, createdName=ms2000000778072906, createdTime=Sun Aug 15 12:17:16 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007915, encodeId=7d01100e915b1, content=需要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/4f10b5177a794339bc579b57c6b95f39/a2c85165c1bc454aa3e382cae54ca6ee.jpg, createdBy=9b2d5573294, createdName=恣意妄为, createdTime=Sat Aug 14 21:27:55 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007735, encodeId=5a75100e735f7, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5185543565, createdName=ms4000000408264698, createdTime=Fri Aug 13 22:35:20 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007527, encodeId=d5e5100e52763, content=作息, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=258a2211002, createdName=120d5e71m96(暂无昵称), createdTime=Fri Aug 13 09:48:42 CST 2021, time=2021-08-13, status=1, ipAttribution=)]
    2021-08-13 120d5e71m96(暂无昵称)

    作息

    0

Baidu
map
Baidu
map
Baidu
map